Evidence map›Paper›PMID 24885983›Full record

ReviewVirology journal2014

Porcine circovirus type 2 in China: an update on and insights to its prevalence and control.

Shao-Lun Zhai, Sheng-Nan Chen, Zhi-Hong Xu, Man-Hua Tang, Feng-Guo Wang, Xiao-Jing Li, Bei-Bei Sun, Su-Fang Deng, Jun Hu, Dian-Hong Lv and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Virology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Shao-Lun Zhai
Sheng-Nan Chen
Zhi-Hong Xu
Man-Hua Tang
Feng-Guo Wang
Xiao-Jing Li
Bei-Bei Sun
Su-Fang Deng
Jun Hu
Dian-Hong Lv
Xiao-Hui Wen
Jie Yuan
Man-Lin LuoCollege of Veterinary Medicine, South China Agricultural University, No, 483 Wushan Road, Tianhe District, Guangzhou 510642, China. luoml@scau.edu.cn.
Wen-Kang Wei
Guangdong Academy of Agricultural Sciences · CNSouth China Agricultural University · CNWen's Food Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, porcine circovirus type 2 (PCV2) is considered the major pathogen of porcine circovirus associated-diseases (PCVAD) that causes large economic losses for the swine industry in the world annually, including China. Since the first report of PCV2 in 1998, it has been drawing tremendous attention for the government, farming enterprises, farmers, and veterinary practitioners. Chinese researchers have conducted a number of molecular epidemiological work on PCV2 by molecular approaches in the past several years, which has resulted in the identification of novel PCV2 genotypes and PCV2-like agents as well as the description of new prevalence patterns. Since late 2009, commercial PCV2 vaccines, including the subunit vaccines and inactivated vaccines, have already been used in Chinese swine farms. The aim of this review is to update the insights into the prevalence and control of PCV2 in China, which would contribute to understanding the epidemiology, control measures and design of novel vaccines for PCV2.

Indexed as

AnimalsChinaCircoviridae InfectionsCircovirusGenotypeMolecular EpidemiologyPrevalenceSwineSwine DiseasesViral VaccinesViral Vaccines

Identifiers

PMID24885983
PMCPMC4031328
OpenAlexW2116700531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.